ARX.AX · AROA BIOSURGERY LIMITED
Australia · RS rating 45 · As of 2026-10-14
| Price | 0.52 AUD |
|---|---|
| 1-day change | +5.0% |
| RS rating (overall / 1M / 3M / 12M) | 45 / 42 / 37 / 47 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 18 / 22 / 14 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +34.0% |
| Market cap (USD) | $126.9M |